Activation of hepatic stellate cells--a key issue in liver fibrosis.
about
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinomaPotential role of thymosin Beta 4 in liver fibrosisTargeting the insulin-like growth factor pathway in hepatocellular carcinomaCytoglobin is a respiratory protein in connective tissue and neurons, which is up-regulated by hypoxiaInteraction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferationModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsExpression and location of Smad2, 4 mRNAs during and after liver fibrogenesis of ratsIdentification and functional characterization of the hepatic stellate cell CD38 cell surface moleculeEffects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liverLiver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cellsLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases.Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-beta signaling.Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure.Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis CThymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling.Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.The role of hepatic myofibroblasts in liver cirrhosis in fallow deer (Dama dama) naturally infected with giant liver fluke (Fascioloides magna)Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model.Future therapy of hepatitis C.Activated hepatic stellate cells express keratinocyte growth factor in chronic liver diseaseSalvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct PathwaysMorphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver.24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.Gallic acid induces necroptosis via TNF-α signaling pathway in activated hepatic stellate cells.Hepatoprotective and antioxidant effects of licorice extract against CCl₄-induced oxidative damage in ratsPancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes.Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosismicroRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice.Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats.Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice.Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA microarray.Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in vitro.Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathwayInflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren's Disease Fibroblasts.
P2860
Q24556510-6F7CD137-82A5-45D6-84AD-C1957520A20FQ27003833-E2377D8F-CAB3-4489-AAD6-C83E2D1DA87FQ27006846-6536D6EE-C839-4F59-8846-C92D5EEB5DE4Q28189861-D58D03D4-FEED-46A7-B4F0-12C3A2CA51C9Q28273742-290E2547-AE8B-439D-921A-EF43E61C656DQ28303698-4F78F13B-330B-4013-A047-CB3F5290DAF5Q28564457-2E662D90-F02C-48D0-8482-3479D5BE34AEQ28573700-59D51A13-58DC-4140-A525-A933EAF7BBC3Q28582815-06DBB154-F8FA-4764-BFB1-6339A69794C9Q30369750-12A5C958-0EC7-4E60-9728-001040001054Q30374500-A6361D8D-BE39-46C1-B9CF-CFC85FE59C4CQ31035350-69A21F4E-8F96-473E-AE28-CED489651552Q33215337-C55232A7-C62D-448C-8BA5-76CC5C7DB379Q33586759-C167A2B3-1BEB-4E86-94C8-85BCF9263020Q33788611-E95FFEFE-B248-417F-AC21-8780F566100FQ33812502-BA71BE7E-F12E-4A48-8725-F64AC85A44EAQ33889618-42AD0803-343B-4F16-A4E8-AF21FBE42845Q34012890-A0AA1787-1BEA-4EB6-8CE9-CED9975B17D1Q34623670-5091C1FB-EA9E-4268-BC12-86A49A38E23AQ34962750-FD41DC26-83B6-4D17-B208-D43A0CEFBE2BQ34984147-4FD0AE50-0F6F-4BD2-9F44-8599B105F233Q35103291-46D4BE67-DAF6-41B3-8F2B-D50B77D40307Q35163498-C346D366-144A-4B09-B1B6-81E2A0E30F64Q35165731-DA815A37-B911-45C6-9688-192EA077DD0EQ35201779-A475D855-7B0D-46DA-9696-D060B8925EDFQ35224659-D5C32383-9DE5-4A6E-8D30-6E989FE98E6EQ35536020-4BFFCB0A-0936-4977-B8E7-53DB1257E05CQ35546368-011FBCD1-AC9B-4B69-A17D-4B3D25576876Q35546429-43115B7A-01CA-497D-99BD-31599A628941Q35740215-2AAD88E9-6EED-479B-8B45-A49896D3DE24Q35765708-85D46479-B5A3-444A-98BC-DF8CC52ADE28Q35777649-3BF1E9EB-BB1E-40A9-923B-CE1F3CD420F1Q35792203-91F16519-DF88-445C-AA60-6F6A3F90B6B0Q35918603-F787484A-F678-4767-A206-42E7935F86C5Q36018045-A32B1792-15F5-440C-8ABB-5B043E622492Q36067494-A24A241D-FEB5-48DB-909D-491729F046F4Q36175084-F8B2C0A8-DB46-4231-8FA3-2941EB2C0F22Q36179842-CB081D4F-57E7-49BA-B20C-D0ACFEAB4C1BQ36328115-362C9A5E-6B7F-4D45-8A95-703B96F6F06DQ36352894-51587198-FF9A-45E1-9706-4B6F28A63087
P2860
Activation of hepatic stellate cells--a key issue in liver fibrosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@ast
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@en
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@nl
type
label
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@ast
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@en
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@nl
prefLabel
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@ast
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@en
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@nl
P356
P1476
Activation of hepatic stellate cells--a key issue in liver fibrosis.
@en
P2093
Helen L Reeves
Scott L Friedman
P304
P356
10.2741/REEVES
P577
2002-04-01T00:00:00Z